BC
IMNM icon

BIT Capital’s Immunome IMNM Stock Holding History

BIT Capital’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
+83,400
New +$1.78M 0.05% 64
2025
Q4 		– Sell
-5,927
Closed -$69.4K – 126
2025
Q3 		$69.4K Buy
+5,927
New +$59K ﹤0.01% 94

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

BIT Capital's IMNM Position: Q2 2026 in Review

BIT Capital opened a new position in Immunome (IMNM) in Q2 2026: 83,400 shares worth $1.77M. The stake represents 0.05% of the portfolio and ranks #64 among its holdings. This is a return to the name: BIT Capital previously reported a position in IMNM as recently as Q3 2025.

BIT Capital first reported a position in IMNM in Q3 2025 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • BIT Capital held 83,400 shares of Immunome worth $1.77M as of Q2 2026.
  • Immunome was a new BIT Capital position in Q2 2026.
  • Immunome made up 0.05% of BIT Capital's portfolio in Q2 2026, its #64 holding.
  • BIT Capital first reported a position in Immunome in Q3 2025 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on BIT Capital's 13F filing for Q2 2026, filed 12 Aug 2026.